1. 2010
  2. Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells

    Hoogwater, F. J. H., Nijkamp, M. W., Smakman, N., Steller, E. J. A., Emmink, B. L., Westendorp, B. F., Raats, D. A. E., Sprick, M. R., Schaefer, U., van Houdt, W. J., de Bruijn, M. T., Schackmann, R. C. J., Derksen, P. W. B., Medema, J-P., Walczak, H., Borel Rinkes, I. H. M. & Kranenburg, O., 2010, In: Gastroenterology. 138, 7, p. 2357-2367

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Potential Role of Soluble TRAIL in Epithelial Injury in Children with Severe RSV Infection

    Bem, R. A., Bos, A. P., Wösten-van Asperen, R. M., Bruijn, M., Lutter, R., Sprick, M. R. & van Woensel, J. B. M., 2010, In: American journal of respiratory cell and molecular biology. 42, 6, p. 697-705

    Research output: Contribution to journalArticleAcademicpeer-review

  4. The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation

    Kemper, K., Sprick, M. R., de Bree, M., Scopelliti, A., Vermeulen, L., Hoek, M., Zeilstra, J., Pals, S. T., Mehmet, H., Stassi, G. & Medema, J. P., 2010, In: Cancer research. 70, 2, p. 719-729

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

    Vermeulen, L., de Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., Sprick, M. R., Kemper, K., Richel, D. J., Stassi, G. & Medema, J. P., 2010, In: Nature cell biology. 12, 5, p. 468-U121

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2009
  7. Tumor microvasculature supports proliferation and expansion of glioma-propagating cells

    Borovski, T., Verhoeff, J. J. C., ten Cate, R., Cameron, K., de Vries, N. A., van Tellingen, O., Richel, D. J., van Furth, W. R., Medema, J. P. & Sprick, M. R., 2009, In: International journal of cancer. Journal international du cancer. 125, 5, p. 1222-1230

    Research output: Contribution to journalArticleAcademicpeer-review

  8. 2008
  9. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2

    Diessenbacher, P., Hupe, M., Sprick, M. R., Kerstan, A., Geserick, P., Haas, T. L., Wachter, T., Neumann, M., Walczak, H., Silke, J. & Leverkus, M., 2008, In: Journal of investigative dermatology. 128, 5, p. 1134-1147

    Research output: Contribution to journalArticleAcademicpeer-review

  10. 2007
  11. Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis

    Koschny, R., Holland, H., Sykora, J., Haas, T. L., Sprick, M. R., Ganten, T. M., Krupp, W., Bauer, M., Ahnert, P., Meixensberger, J. & Walczak, H., 2007, In: Clinical cancer research. 13, 11, p. 3403-3412

    Research output: Contribution to journalArticleAcademicpeer-review

  12. TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window

    Koschny, R., Ganten, T. M., Sykora, J., Haas, T. L., Sprick, M. R., Kolb, A., Stremmel, W. & Walczak, H., 2007, In: Hepatology (Baltimore, Md.). 45, 3, p. 649-658

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 86727